RODMAN&RENSHAW Stock Recommendations and Price Targets

This is a list of recent ratings by RODMAN&RENSHAW.

DateCompany NameActionCurrent
Price
Price
Target
Rating
3/19/2025
BTAI
BioXcel Therapeutics
Upgrade$2.00Strong-Buy
2/20/2025
TELO
Telomir Pharmaceuticals
Upgrade$1.00Strong-Buy
1/28/2025
TLPH
Talphera
Upgrade$1.00Strong-Buy
1/28/2025
CRDL
Cardiol Therapeutics
Upgrade$1.00Strong-Buy
1/28/2025
PYPD
PolyPid
Upgrade$4.00Strong-Buy
1/28/2025
INMB
INmune Bio
Upgrade$2.00Strong-Buy
1/28/2025
INDV
Indivior
Upgrade$35.00Strong-Buy
1/21/2025
ATRA
Atara Biotherapeutics
Downgrade$14.00Strong-Buy ➝ Hold
12/20/2024
ATRA
Atara Biotherapeutics
Upgrade$14.00Strong-Buy
12/19/2024
HURA
TuHURA Biosciences
Upgrade$2.00Strong-Buy
12/6/2024
THAR
Tharimmune
Upgrade$2.00Strong-Buy
11/14/2024
ADIL
Adial Pharmaceuticals
Upgrade$0.00Strong-Buy
11/14/2024
RMTI
Rockwell Medical
Upgrade$1.00Strong-Buy
11/14/2024
EPRX
Eupraxia Pharmaceuticals
Upgrade$6.00Strong-Buy
11/14/2024
ACHV
Achieve Life Sciences
Upgrade$5.00Strong-Buy
11/14/2024
OMER
Omeros
Upgrade$11.00Strong-Buy
11/5/2024
BCAX
Bicara Therapeutics
Upgrade$19.00Strong-Buy
10/29/2024
QNCX
Quince Therapeutics
Upgrade$4.00Strong-Buy
10/23/2024
ANRO
Alto Neuroscience
Downgrade$13.00Strong-Buy ➝ Hold
10/9/2024
NKTX
Nkarta
Upgrade$2.00Strong-Buy
10/9/2024
KYTX
Kyverna Therapeutics
Upgrade$8.00Strong-Buy
9/30/2024
MIRA
MIRA Pharmaceuticals
Upgrade$1.00Strong-Buy
9/26/2024
BMEA
Biomea Fusion
Upgrade$1.00Strong-Buy